Table 3 The average survival time, median survival time and significant difference between C6 tumor-bearing nude mice in different groups (*p < 0.05, **p < 0.001, n = 9).

From: Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy

Group

Average survival time (d)

Median survival time (d)

Significant difference

Control

Cur-solution

Cur-Nio

TF-Cur-Nio

Control

16.12 ± 2.532

16

    

Cur-solution

17.63 ± 2.875

17

*

   

Cur-Nio

19 ± 3.071

20

**

*

  

TF-Cur-Nio

23.5 ± 3.381

22

**

**

**

**